This report is useful for M&A, business & investment analysis to all students, researchers, investors, private equity houses, broking firms, hedge funds, advisory firms and corporates to decide upon their investment strategies. Do connect with us, if you are looking for equity valuation, recommendation, analysis and market recommendation for any specific company, sector and industry.

Since the onset of COVID-19 in early 2020, the industry has faced several challenges to maintain stable growth. The rising need to work from home has drastically surged networking & communication, and data processing applications worldwide which will lead to the moderate growth of the market for semiconductors in the long term.

 According to the Semiconductor Industry Association (SIA), Global semiconductor industry sales were $46.9 billion during the month of October 2022, a slight decrease of 0.3% compared to the September 2022 total of $47.0 billion and down 4.6% compared to the October 2021 total of $49.1 billion.

 In 2021, the global semiconductor revenue increased by 26.3%; in 2022, it is expected to fall to just 7.4%. Additionally, it is less than the 13.6% growth forecast for 2022 from the previous quarter. The semiconductor market is also expected to decline by 2.8% through 2023 as it enters a period of weakness. But when looked at it from a longer term perspective, the market is projected to grow from USD 573.44 billion in 2022 to USD 1,380.79 billion in 2029, exhibiting a CAGR of 12.2% during the forecast period.

Executive Summary

• Key Players
• Analog Devices, Inc.
• Applied Materials Inc.
• Advanced Micro Devices Inc.
• ASML Holding NV
• Broadcom Inc.
• Intel Corporation
• Lam Research Corporation
• Microchip Technology Inc.
• Micron Technology, Inc.
• Nvidia Corporation
• NXP Semiconductors N.V.
• Qualcomm, Inc.
• Qorvo, Inc.
• STMicroelectronics N.V.
• Skyworks Solutions, Inc.
• Teradyne Inc.
• Taiwan Semiconductor Manufacturing Co Ltd
• Texas Instruments Inc

This report was produced by a member company of the Crispidea. This report is for the use of intended recipients only and may not be reproduced (in whole or in part) or delivered or transmitted to any other person without our prior written consent. By accepting this report, the recipient agrees to be bound by the terms and limitations set out herein.